Atterogen Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Atterogen General Information
Description
Provider of novel enzyme therapy intended to target aberrant glycogen metabolism and improve brain metabolic dysfunction in Alzheimer's disease. The company is currently operating in Stealth mode.
Contact Information
Corporate Office
- 3248 Marston Place
- Lexington, KY 40503
- United States
Corporate Office
- 3248 Marston Place
- Lexington, KY 40503
- United States
Atterogen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 01-Sep-2022 | Completed | Stealth |
Atterogen Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Atterogen Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Launch Blue | Accelerator/Incubator |
Atterogen FAQs
-
When was Atterogen founded?
Atterogen was founded in 2021.
-
Where is Atterogen headquartered?
Atterogen is headquartered in Lexington, KY.
-
What industry is Atterogen in?
Atterogen’s primary industry is Clinics/Outpatient Services.
-
Is Atterogen a private or public company?
Atterogen is a Private company.
-
What is Atterogen’s current revenue?
The current revenue for Atterogen is .
-
Who are Atterogen’s investors?
Launch Blue has invested in Atterogen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
